321 related articles for article (PubMed ID: 3337513)
1. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA
Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
3. Sepsis in febrile neutropenic children with cancer.
Langley J; Gold R
Pediatr Infect Dis J; 1988 Jan; 7(1):34-7. PubMed ID: 3340456
[TBL] [Abstract][Full Text] [Related]
4. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
Verhagen CS; de Pauw B; de Witte T; Janssen J; Williams K; de Mulder P; Bothof T
Antimicrob Agents Chemother; 1987 Feb; 31(2):191-6. PubMed ID: 3551829
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
[TBL] [Abstract][Full Text] [Related]
7. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
[TBL] [Abstract][Full Text] [Related]
8. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
[TBL] [Abstract][Full Text] [Related]
10. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
Roongpoovapatr P; Suankratay C
J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
[TBL] [Abstract][Full Text] [Related]
12. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
[TBL] [Abstract][Full Text] [Related]
14. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
Adcock KG; Akins RL; Farrington EA
Pharmacotherapy; 1999 Nov; 19(11):1315-20. PubMed ID: 10555937
[TBL] [Abstract][Full Text] [Related]
17. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
18. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons.
Feld R
Clin Infect Dis; 1999 Sep; 29(3):503-7. PubMed ID: 10530436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
